This article discusses the presentation of Dr. Ute Krüger, a cancer pathologist from the Pandemic Strategies, Lessons, and Consequences Conference in Stockholm, Sweden, in January 2023.
Her presentation is, Sabotage? – A Pathologist’s Report, and is a 26:25 minute presentation available here.
I watched its entirety, and her report is very concerning to me, who has written a lot about the complications of the COVID “vaccines.”
All slides are from her presentation, and all quotes are from Dr. Krugër.
Dr. Ute Krüger’s background
Ute Krüger MD, DMedSci, is a pathologist educated in Germany and now living and working in Sweden. She wrote her doctoral thesis at the Humboldt University in Berlin on analyzing 7500 autopsy protocols.
With over 25 years of experience in Clinical Pathology and a special interest in breast cancer, Ute has been researching breast cancer at Lund University for almost eight years. She has evaluated 1500 breast cancer cases.
She was a member of the Swedish Association of Pathologists Board and was previously the Medical Chief of the Department of Clinical Pathology in Växjö. She works as a Senior Physician in the Department of Clinical Pathology in Kalmar.
With that experience, she knew the average age distribution, tumor size, and degree of malignancy of the daily input of new material for breast cancer.
Turbokrebs – Turbo Cancers
In autumn 2021, breast cancer cases changed.
- Women who have breast cancer became younger, 30 – 50 years old.
- Tumors were growing more aggressively, faster, and larger.
- More than four centimeters was not uncommon.
- Dr. Ute has seen breast cancers of more than 16 cm (6.29 inches)
- Multifocal and bilateral breast cancers became more frequent.
Tumor aggressiveness
Below is a typical breast papilloma (not cancer) stained with Hematoxylin and Eosin (HE). The pink is the stroma or connective tissue, blood vessels, and ducts surrounding the breast papilloma in the middle, shown as an aggregation of purple dots.
Below is an aggressively growing tumor presenting as a solid tumor mass with a small amount of stroma. The papilloma cells are slightly larger.
Tumor Aggressiveness
Rapid cell division makes cancer cells grow fast. The rate of cancer growth can be seen visually as an increase in size or spread (metastasis).
Ki67 staining is used in histopathology to define the rate of cell division or proliferation. It is a measure of tumor growth aggressiveness. Typically, two-thirds of breast cancers have low proliferation. One-third of breast cancers are highly proliferative.
The image below shows a tumor with low proliferative activity. Less than 10% of the nuclei are stained brown with Ki67.
Below is a fast-growing tumor with about 70% stained brown. Two-thirds of the cells are in cell division. These tumors are more common now in Dr. Ute’s practice.
Multifocal Tumors
Multifocal breast cancer means more than one tumor is present in one breast.
Multifocality – Case 1
- 55-year-old woman
- Has a COVID jab a few months before
- Sectoral resection (one part of the breast)
- 130 mm ductal carcinoma in situ – cancer in the mammary ducts
- 20 invasive ductal carcinoma, the largest is 35 mm (1.38 inches)
The image below shows multifocality. The area with the intraductal carcinoma is marked in blue. There are several invasive foci marked with red. The tumor showed far more aggressive behavior in the lymphatic tissues outside the breast. Four lymph nodes were affected.
Recurrences
These patients include those who had breast cancers before and are considered cured. It can be cancer from 20 years ago.
Soon after a COVID “vaccine,” there is a pronounced growth and spread of the tumor inside the body, and some patients die within a few months.
Recurrence- Case 2
- 80-year-old woman
- Sectoral resection (part of a breast removed) seven years ago
- Breast cancer recurrence three months after the vaccination
- 55 mm (2.17 in) breast cancer
- several skin metastasis on the same site
This type of aggressive recurrence is a very uncommon condition.
Another slide on breast cancer recurrence is shown below. The area in green marks the previous surgery and shows scar tissue. The area in red is breast cancer recurrence.
The direct proximity of the recurrence to the scar tissue is impressive.
In breast cancer surgery, the surgeon ensures that the surrounding normal breast tissue is removed.
Tumor Heterogeneity or Patterns
Tumor heterogeneity – Case 3
- 70- year-old woman
- Breast cancer, lobular type (a slow-growing breast cancer)
- For three years, she had metastasis in her urinary bladder, intestines, bones, and liver.
- After the COVID vaccination, the tumors exploded
- Death within a month
The patient’s doctor said the liver metastasis grew unusually fast compared to the other metastases.
The liver slide is shown below; on your right side is the normal liver tissue. The middle part is lobular breast cancer metastasis that is slow growing with small nuclei and clearly visible stroma. On your left is the new rapidly growing breast cancer metastasis.
Coincident tumors
In 2022, Dr. Ute had three cases within three weeks, with three concurrent carcinomas in different organs a few months after the COVID shots.
One woman – three primary tumors
- Breast cancer
- Lung cancer
- Pancreatic cancer
These are very unusual and remarkable.
Tumor Conferences
Pathologists gather in tumor conferences yearly to discuss their cases. Last year, Dr. Ute presented 35 cases considering that she works in a small hospital. Last year’s conference had the most cases compared to the previous 19 years.
A pathologist specializing in bladder diseases confided to Dr. Ute that tumor conferences are becoming more and more complicated.
Benign Breast Tumors
Tumors can be benign or malignant. Another anomaly that Dr. Ute observed is the increased number of fibroepithelial breast tumors.
Below is a fibroadenoma marked in blue that shows an older fibroadenoma with a little proliferative stroma and has not grown in the last few months.
The area in red is the rapidly growing proliferative area of the tumor.
I see more changes in benign breast fibroadenomas more frequently now.
Sometimes a patient goes to their doctor complaining of pain on palpation of the breast, which may be from inflammation.
Inflammation
The slide below explains the inflammation. It shows a milk duct with the immediate surrounding area infiltrated with lymphocytes. Lymphocytes are white blood cells that secrete inflammatory cytokines. The inflammation is felt as swelling and pain.
It is not unusual for me to see vasculitic like changes in the mammary parenchyma. That means inflammation in the small blood vessels of the breast.
After a presentation last year, Turbocancer due to COVID vaccination? It received several 1300 comments from people who knew someone who had or knew someone who had turbo cancer. She shares one comment.
Maybe it’s a coincidence, maybe not… I developed symptoms after the second vaccination. After two months, I was diagnosed with terminal lung cancer. I am currently doing well… although the doctors said I only had 6-12 months to live…
I am male, just under 40 years old, father of small children, a non-smoker, and have not drunk alcohol for x years. I will never find out if the vaccination is to blame…
The man’s lifestyle above does not match the highly aggressive course of lung cancer. He reminds me of the 90-year-old man who is a non-smoker, a non-drinker with mild coronary atherosclerosis with a fatal aortic dissection. – Aortic Dissection after the Pfizer injection
Statistics?
In this part, Dr. Krugër talks about how some hospital practices can affect cancer statistics.
The first is that cancer sizes are based on the surgical specimens submitted and not the pre-surgical size. Often patients with large cancers get preoperative chemotherapy which shrinks the tumor.
Another way is that adjuvant chemotherapy is done before surgeries can cure aggressive breast tumors like HER2-positive and Triple-negative tumors.
HER2 is a protein that helps tumors grow faster. Triple-negative tumors mean that hormonal receptors and HGER2 receptors are negative. They also grow quickly.
Dr. Krugër recommends that large studies should be done regarding multifocal and bilateral tumors from multiple institutes, preferably cross-national, to prove or disprove post-vaccination turbo cancers.
Autopsy
Dr, Krugër has done three autopsies that she suspects to be related to the COVID shots. One of them was published as a case report.
Her other cases are similar to what Dr. Arne Burkhardt showed in this presentation, New and Alarming Autopsy Findings after the COVID shots.
- Failure of autopsy
- Misreporting of clinicians – many deceased are reported by their physicians to be unvaccinated, where in fact, they are.
- Lack of histological examination – Dr. Burkhardt exemplified this on New and Alarming Autopsy Findings after the COVID shots.
- Inexperience in histological assessment
Yopu only see what you know – Johann Wolfgang von Goethe
You only see what you know and what you want to see – Dr. Ute Krugër
More on Dr. Krugër’s presentation here.
Cause of turbo cancer
The body’s immune system monitors and destroys cancer cells with its DNA repair mechanisms using the BRCA1 and 53BP1 Checkpoint Proteins.
A peer-reviewed study was published in the journal Viruses in October 2021, SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro.
Many articles about the findings showed that the mRNA COVID jabs could allow cancer cells to proliferate. I wrote a piece about it too.
Study: SARS-CoV-2 Spike Proteins Impaired DNA Repair That Can Lead to Defective Immunity and Cancers
Months later, I learned that the authors, Hui Jiang and Ya-Fang Me, based in Sweden, where the Pandemic Strategies Conference was also held, retracted their study.
I guess the authors were pressured to retract their study to remove damning material for those who want to write against forced vaccinations. A threat to remove further grants is enough can convince any investigator.
I did not pull my article even though I knew about the retraction because it was already peer-reviewed, and the study design was sound. At least, in my view.
Cancer cases have continued to increase since.
- The Carcinogenic Effects of the SARS-CoV-2
- Rapid Progression of a Lymphoma following Pfizer booster shot
In 2019, before the pandemic, the American Cancer Society (ACS) estimated 1,762,450 new cancer cases and 606,880 cancer deaths in the United States.
For 2022, the ACS estimates there will be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.
Personal Note
I know people who died rapidly after their diagnosis of cancer who had COVID shots. One is a woman in her 60s who died within six months after her breast cancer recurred. Another is in her 40s and succumbed to her rapidly growing breast cancer.
Do you know any?
Truth heals. Lies kill. Don’t Get Sick!
Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.
Follow me on Gettr, Truth Social, Gab, Parler, Twitter, Facebook, Follow, and Telegram.
If you find value in this website, please consider buying a coffee to show your support.
© 2018 – 2023 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases.